CZ24797A3 - Polymorphs of lesopitron dihydrochloride and their hydrated forms, process of their preparation and pharmaceutical composition containing thereof - Google Patents

Polymorphs of lesopitron dihydrochloride and their hydrated forms, process of their preparation and pharmaceutical composition containing thereof Download PDF

Info

Publication number
CZ24797A3
CZ24797A3 CZ97247A CZ24797A CZ24797A3 CZ 24797 A3 CZ24797 A3 CZ 24797A3 CZ 97247 A CZ97247 A CZ 97247A CZ 24797 A CZ24797 A CZ 24797A CZ 24797 A3 CZ24797 A3 CZ 24797A3
Authority
CZ
Czechia
Prior art keywords
polymorph
lesopitron dihydrochloride
hydrate
dihydrochloride
lesopitron
Prior art date
Application number
CZ97247A
Other languages
Czech (cs)
English (en)
Inventor
Roses Pilar Lupon
Navarro Jaime Tomas
Torres Salvador Puig
Constansa Jordi Frigola
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of CZ24797A3 publication Critical patent/CZ24797A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ97247A 1995-05-31 1996-05-29 Polymorphs of lesopitron dihydrochloride and their hydrated forms, process of their preparation and pharmaceutical composition containing thereof CZ24797A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.

Publications (1)

Publication Number Publication Date
CZ24797A3 true CZ24797A3 (en) 1997-05-14

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ97247A CZ24797A3 (en) 1995-05-31 1996-05-29 Polymorphs of lesopitron dihydrochloride and their hydrated forms, process of their preparation and pharmaceutical composition containing thereof

Country Status (29)

Country Link
US (1) US5872125A (da)
EP (1) EP0771798A1 (da)
JP (1) JPH10503532A (da)
CN (1) CN1076020C (da)
AR (1) AR003952A1 (da)
AU (1) AU699210B2 (da)
BG (1) BG62966B1 (da)
CA (1) CA2196425A1 (da)
CO (1) CO4700461A1 (da)
CZ (1) CZ24797A3 (da)
EE (1) EE9700067A (da)
ES (1) ES2099031B1 (da)
GE (1) GEP20002241B (da)
HU (1) HUP9700284A3 (da)
IL (1) IL118494A0 (da)
IN (1) IN186820B (da)
IS (1) IS4420A (da)
MA (1) MA23883A1 (da)
MX (1) MX9700792A (da)
NO (1) NO310073B1 (da)
NZ (1) NZ308110A (da)
PL (1) PL318280A1 (da)
RU (1) RU2178789C2 (da)
SK (1) SK12697A3 (da)
TR (1) TR199600455A2 (da)
UY (1) UY24241A1 (da)
WO (1) WO1996038439A1 (da)
YU (1) YU32396A (da)
ZA (1) ZA964139B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
GEP20002241B (en) 2000-09-25
PL318280A1 (en) 1997-06-09
IS4420A (is) 1997-01-29
CA2196425A1 (en) 1996-12-05
WO1996038439A1 (es) 1996-12-05
AU5765096A (en) 1996-12-18
UY24241A1 (es) 1996-06-14
HUP9700284A3 (en) 1998-01-28
CN1076020C (zh) 2001-12-12
IL118494A0 (en) 1996-09-12
CN1158128A (zh) 1997-08-27
AU699210B2 (en) 1998-11-26
RU2178789C2 (ru) 2002-01-27
EE9700067A (et) 1997-10-15
BG101176A (en) 1997-08-29
HU9700284D0 (en) 1997-04-28
AR003952A1 (es) 1998-09-30
NO970392D0 (no) 1997-01-29
EP0771798A1 (en) 1997-05-07
BG62966B1 (bg) 2000-12-29
IN186820B (da) 2001-11-17
ES2099031A1 (es) 1997-05-01
MX9700792A (es) 1997-05-31
HUP9700284A2 (en) 1997-11-28
NZ308110A (en) 1997-08-22
MA23883A1 (fr) 1996-12-31
NO310073B1 (no) 2001-05-14
CO4700461A1 (es) 1998-12-29
ZA964139B (en) 1997-02-06
TR199600455A2 (tr) 1996-12-21
ES2099031B1 (es) 1997-12-01
US5872125A (en) 1999-02-16
JPH10503532A (ja) 1998-03-31
YU32396A (sh) 1999-07-28
NO970392L (no) 1997-04-01
SK12697A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
CZ289216B6 (cs) Trihydrát methansulfonátu 5-(2-(4-(1,2-benzizothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-onu, farmaceutická kompozice a léčivo na jeho bázi
JP2005507423A (ja) グリコーゲン合成酵素キナーゼ３ベータ阻害剤（ｇｓｋ３阻害剤）としてのヘテロアリールアミン
EP2691394B1 (en) Compounds for treatment of metabolic syndrome
EP0258755A1 (en) Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
JPS63280081A (ja) 置換イミダゾリル−アルキル−ピペラジンおよび−ジアゼピン誘導体
BRPI0509595B1 (pt) Processos para a preparação de cristais de forma a e de material de padrão c de bissulfato de atazanavir
ZA200005153B (en) Novel crystalline forms of an antiviral benzimidazole compound.
EP1559715B1 (en) N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
US20010049439A1 (en) Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
JP7168447B2 (ja) ビラスチンの結晶形態及びそれらの調製方法
RU2245334C2 (ru) Производные пиперазинилалкилтиопиримидина, содержащие их фармацевтические композиции и способ получения
JP2022530441A (ja) ７ｈ－ピロロ［２，３－ｄ］ピリミジンｊａｋ－阻害剤
JP6838045B2 (ja) 化合物
CS262690B2 (en) Process for preparing 1-/hydroxystyryl/-5h-2,3-benzodiazepines
DE3423092A1 (de) Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
EP0437415A2 (de) Kristallform des 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)-benzonitril-hydrochlorids
CZ24797A3 (en) Polymorphs of lesopitron dihydrochloride and their hydrated forms, process of their preparation and pharmaceutical composition containing thereof
KR100573635B1 (ko) 형태 Ⅵ의 5,6-디클로로-2-(이소프로필아미노)-1-(β-Ｌ-리보푸라노실)-1Ｈ-벤즈이미다졸
JPH01249757A (ja) 血糖低下剤としてのピペラジニルアルキルピリミジン
CN104610364B (zh) 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用
NZ208956A (en) Pyrimidone derivatives
JP2000514460A (ja) Ｎ−（４−アセチル−１−ピペラジニル）−４−フルオロベンズアミド水和物
DE69809564T2 (de) 2- 4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung
JPH02292287A (ja) プテリジン化合物及び該化合物を含有する抗不整脈、心臓保護、抗カリ尿及び利尿作用を有する組成物
US2194190A (en) Pyrimidine compound

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic